The US FDA has approved a new non-opioid painkiller, Journavx, by Vertex Pharmaceuticals, which targets pain signals before reaching the brain to provide relief for moderate to severe pain without the addictive potential of opioids. Clinical trials showed effectiveness in reducing post-surgery pain, marking an important milestone in acute pain management amidst the opioid crisis in the US. Priced at $15.50 per capsule, Journavx is the first new class of pain medicine approved in over 20 years, offering hope for the 80 million Americans prescribed pain medication annually.
Full Article
Two British brothers drown in front of dad while swimming on holiday
Two British brothers, aged 11 and 13, tragically drowned while swimming at Llarga Beach in Salou, Spain, in front of their father, who was rescued alive. Their deaths mark the 15th and 16th fatalities on Catalan beaches this summer, prompting authorities to emphasize the importance of safety precautions near water. Want More Context? 🔎
Read more